Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.

Jacquelot N, Seillet C, Wang M, Pizzolla A, Liao Y, Hediyeh-Zadeh S, Grisaru-Tal S, Louis C, Huang Q, Schreuder J, Souza-Fonseca-Guimaraes F, de Graaf CA, Thia K, Macdonald S, Camilleri M, Luong K, Zhang S, Chopin M, Molden-Hauer T, Nutt SL, Umansky V, Ciric B, Groom JR, Foster PS, Hansbro PM, McKenzie ANJ, Gray DHD, Behren A, Cebon J, Vivier E, Wicks IP, Trapani JA, Munitz A, Davis MJ, Shi W, Neeson PJ, Belz GT

Open source

DOI: 10.1038/s41590-021-00943-z
Published: 2021 Jul
Container: Nature immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41590-021-00943-z,
  title = {Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.},
  author = {Jacquelot N and Seillet C and Wang M and Pizzolla A and Liao Y and Hediyeh-Zadeh S and Grisaru-Tal S and Louis C and Huang Q and Schreuder J and Souza-Fonseca-Guimaraes F and de Graaf CA and Thia K and Macdonald S and Camilleri M and Luong K and Zhang S and Chopin M and Molden-Hauer T and Nutt SL and Umansky V and Ciric B and Groom JR and Foster PS and Hansbro PM and McKenzie ANJ and Gray DHD and Behren A and Cebon J and Vivier E and Wicks IP and Trapani JA and Munitz A and Davis MJ and Shi W and Neeson PJ and Belz GT},
  year = {2021},
  journal = {Nature immunology},
  doi = {10.1038/s41590-021-00943-z},
  url = {https://doi.org/10.1038/s41590-021-00943-z}
}

RIS

TY  - JOUR
TI  - Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
AU  - Jacquelot N
AU  - Seillet C
AU  - Wang M
AU  - Pizzolla A
AU  - Liao Y
AU  - Hediyeh-Zadeh S
AU  - Grisaru-Tal S
AU  - Louis C
AU  - Huang Q
AU  - Schreuder J
AU  - Souza-Fonseca-Guimaraes F
AU  - de Graaf CA
AU  - Thia K
AU  - Macdonald S
AU  - Camilleri M
AU  - Luong K
AU  - Zhang S
AU  - Chopin M
AU  - Molden-Hauer T
AU  - Nutt SL
AU  - Umansky V
AU  - Ciric B
AU  - Groom JR
AU  - Foster PS
AU  - Hansbro PM
AU  - McKenzie ANJ
AU  - Gray DHD
AU  - Behren A
AU  - Cebon J
AU  - Vivier E
AU  - Wicks IP
AU  - Trapani JA
AU  - Munitz A
AU  - Davis MJ
AU  - Shi W
AU  - Neeson PJ
AU  - Belz GT
PY  - 2021
JO  - Nature immunology
DO  - 10.1038/s41590-021-00943-z
UR  - https://doi.org/10.1038/s41590-021-00943-z
ER  -

APA

N, J., C, S., M, W., A, P., Y, L., S, H., S, G., C, L., Q, H., J, S., F, S., CA, D. G., K, T., S, M., M, C., K, L., S, Z., M, C., T, M., SL, N., V, U., B, C., JR, G., PS, F., PM, H., ANJ, M., DHD, G., A, B., J, C., E, V., IP, W., JA, T., A, M., MJ, D., W, S., PJ, N., & GT, B. (2021). Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.. Nature immunology. https://doi.org/10.1038/s41590-021-00943-z

Source records

pubmed · retrieved 2026-09-25T22:54:22.625Z